Request a document copy: Oral administration of a new HRI activator as a new strategy to improve high-fat-died-induced glucose intolerance, hepatic steatosis and hypertriglyceridemia through FGF21

Requester name:

Requester e-mail:

Files:

all files (of this document) in restricted access

the file(s) you requested

Message:

Cancel Send